Literature DB >> 15671757

Temporary CD8+ T-cell depletion in pigs does not exacerbate infection with porcine reproductive and respiratory syndrome virus (PRRSV).

Louise Lohse1, Jens Nielsen, Lis Eriksen.   

Abstract

Several studies have demonstrated a consistent increase in the CD8+ T-cell subset of pigs following infection with porcine reproductive and respiratory virus (PRRSV). Consequently, it has been suggested that CD8+ T-cells may play an important role in protection against this infection. In order to test this hypothesis, we examined five 5-week-old pigs, which had been depleted for CD8+ T-cells by treatment with anti-CD8 mAb injections, starting 2 days before inoculation with PRRSV. Virus-inoculated and sham-inoculated age-matched pigs served as controls. Blood samples were collected continuously, together with organ material at necropsy, to study kinetics of leukocyte subpopulations, antibody production and virus persistence in individual pigs. Significant lower CD8+ T-cell counts on day 0, that is, before virus challenge, in the anti-CD8 mAb treated pigs compared to the control pigs, confirmed the depletion effect of specific mAb therapy. Almost complete depletion of cell subsets expressing the CD8+ antigen was obtained on day 2 and 5 post infection (PI) with nadir less than 1% of peripheral blood mononuclear cells (PBMC). One week PI, an increase in T-cell subsets was observed for both anti-CD8 mAb treated pigs and virus-inoculated control pigs. T-memory cells and cytotoxic T-cells reached levels comparative with the virus-inoculated control pigs on days 8 and 12 PI, respectively, whereas NKcells remained suppressed for the rest of the experimental period. An extraordinary increase of T-helper cells in the anti-CD8 mAb treated pigs with a significantly higher level than in the virus-inoculated and sham-inoculated control pigs, was observed from day 12 PI. In conclusion, it was established that CD8+ T-cell depletion in the early phase of PRRSV infection neither caused increased disease nor influenced the ability to clear virus in the treated pigs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15671757     DOI: 10.1089/vim.2004.17.594

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  8 in total

1.  A study on the applicability of implantable microchip transponders for body temperature measurements in pigs.

Authors:  Louise Lohse; Ase Uttenthal; Claes Enøe; Jens Nielsen
Journal:  Acta Vet Scand       Date:  2010-05-05       Impact factor: 1.695

2.  Pathogenesis and antigenic characterization of a new East European subtype 3 porcine reproductive and respiratory syndrome virus isolate.

Authors:  Uladzimir U Karniychuk; Marc Geldhof; Merijn Vanhee; Jan Van Doorsselaere; Tamara A Saveleva; Hans J Nauwynck
Journal:  BMC Vet Res       Date:  2010-06-04       Impact factor: 2.741

3.  A porcine circovirus type 2 (PCV2) mutant with 234 amino acids in capsid protein showed more virulence in vivo, compared with classical PCV2a/b strain.

Authors:  Longjun Guo; Yujie Fu; Yiping Wang; Yuehua Lu; Yanwu Wei; Qinghai Tang; Peihu Fan; Jianbo Liu; Long Zhang; Feiyan Zhang; Liping Huang; Dan Liu; Shengbin Li; Hongli Wu; Changming Liu
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

4.  Prediction and in vitro verification of potential CTL epitopes conserved among PRRSV-2 strains.

Authors:  Simon Welner; Morten Nielsen; Michael Rasmussen; Søren Buus; Gregers Jungersen; Lars Erik Larsen
Journal:  Immunogenetics       Date:  2017-06-07       Impact factor: 2.846

5.  Increased Neutralizing Antibody Production and Interferon-γ Secretion in Response to Porcine Reproductive and Respiratory Syndrome Virus Immunization in Genetically Modified Pigs.

Authors:  Guangping Huang; Xianyong Liu; Xiaoli Tang; Li Du; Wenhai Feng; Xiaoxiang Hu; Liangquan Zhu; Qiuyan Li; Xun Suo
Journal:  Front Immunol       Date:  2017-09-12       Impact factor: 7.561

Review 6.  Innate and adaptive immunity against Porcine Reproductive and Respiratory Syndrome Virus.

Authors:  Crystal L Loving; Fernando A Osorio; Michael P Murtaugh; Federico A Zuckermann
Journal:  Vet Immunol Immunopathol       Date:  2015-07-17       Impact factor: 2.046

7.  Efficacy of Fostera® PRRS modified live virus (MLV) vaccination strategy against a Thai highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) infection.

Authors:  Ponlakrit Charoenchanikran; Roongtham Kedkovid; Chaitawat Sirisereewan; Yonlayong Woonwong; Jirapat Arunorat; Panchan Sitthichareonchai; Natthawan Sopipan; Suphattra Jittimanee; Sawang Kesdangsakonwut; Roongroje Thanawongnuwech
Journal:  Trop Anim Health Prod       Date:  2016-06-17       Impact factor: 1.893

8.  Pigs that recover from porcine reproduction and respiratory syndrome virus infection develop cytotoxic CD4+CD8+ and CD4+CD8- T-cells that kill virus infected cells.

Authors:  Chungwon J Chung; Sang-Ho Cha; Amanda L Grimm; Dharani Ajithdoss; Joanna Rzepka; Grace Chung; Jieun Yu; William C Davis; Chak-Sum Ho
Journal:  PLoS One       Date:  2018-09-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.